Oncogenic osteomalacia--a complex dance of factors - PubMed (original) (raw)

Editorial

. 2003 Apr 24;348(17):1705-8.

doi: 10.1056/NEJMe030037.

• PMID: 12711747
• DOI: 10.1056/NEJMe030037

Editorial

Oncogenic osteomalacia--a complex dance of factors

Thomas O Carpenter. N Engl J Med. 2003.

No abstract available

PubMed Disclaimer

Comment on

• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
  Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H. Jonsson KB, et al. N Engl J Med. 2003 Apr 24;348(17):1656-63. doi: 10.1056/NEJMoa020881. N Engl J Med. 2003. PMID: 12711740

Similar articles

• [Tumor-induced rickets/osteomalacia].
  Fukumoto S. Fukumoto S. Nihon Rinsho. 2006 Jun 28;Suppl 2:96-9. Nihon Rinsho. 2006. PMID: 16817359 Review. Japanese. No abstract available.
• [Tumor-induced rickets/osteomalacia].
  Fukumoto S. Fukumoto S. Nihon Rinsho. 2005 Oct;63 Suppl 10:523-8. Nihon Rinsho. 2005. PMID: 16279694 Review. Japanese. No abstract available.
• Tumor-induced osteomalacia.
  Hewison M. Hewison M. Curr Opin Rheumatol. 1994 May;6(3):340-4. doi: 10.1097/00002281-199405000-00017. Curr Opin Rheumatol. 1994. PMID: 8060772 Review.
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
  Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H. Jonsson KB, et al. N Engl J Med. 2003 Apr 24;348(17):1656-63. doi: 10.1056/NEJMoa020881. N Engl J Med. 2003. PMID: 12711740
• [Tumor-induced hypophosphatemic osteomalacia].
  Ito N, Fukukmoto S. Ito N, et al. Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):731-6. doi: 10.2169/naika.96.731. Nihon Naika Gakkai Zasshi. 2007. PMID: 17506312 Review. Japanese. No abstract available.

Cited by

• Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: a case report.
  Chokyu I, Ishibashi K, Goto T, Ohata K. Chokyu I, et al. J Med Case Rep. 2012 Jul 2;6:181. doi: 10.1186/1752-1947-6-181. J Med Case Rep. 2012. PMID: 22747833 Free PMC article.
• Phosphaturic Mesenchymal Tumor-induced Osteomalacia Masquerading as an Orthopedic Polytrauma Patient: A Case Report and Review of the Literature.
  Robles AS, Rockov ZA, Brien EW, Little MTM. Robles AS, et al. J Orthop Case Rep. 2022 Nov;12(11):28-33. doi: 10.13107/jocr.2022.v12.i11.3402. J Orthop Case Rep. 2022. PMID: 37013236 Free PMC article.
• Inorganic phosphate and the risk of cancer in the Swedish AMORIS study.
  Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, Holmberg L, Van Hemelrijck M. Wulaningsih W, et al. BMC Cancer. 2013 May 24;13:257. doi: 10.1186/1471-2407-13-257. BMC Cancer. 2013. PMID: 23706176 Free PMC article.
• Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
  Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Jüppner H, Lanske B. Sitara D, et al. Matrix Biol. 2004 Nov;23(7):421-32. doi: 10.1016/j.matbio.2004.09.007. Matrix Biol. 2004. PMID: 15579309 Free PMC article.
• FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.
  Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. Riminucci M, et al. J Clin Invest. 2003 Sep;112(5):683-92. doi: 10.1172/JCI18399. J Clin Invest. 2003. PMID: 12952917 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Miscellaneous

  • NCI CPTAC Assay Portal